Works matching IS 19466234 AND DT 2014 AND VI 6 AND IP 261

Results: 5

Public Biobanks: Calculation and Recovery of Costs.
Published in:
Science Translational Medicine, 2014, v. 6, n. 261, p. 1, doi. 10.1126/scitranslmed.3010444
By:
- Clément, Bruno;
- Yuille, Martin;
- Zaltoukal, Kurt;
- Wichmann, Heinz-Erich;
- Anton, Gabriele;
- Parodi, Barbara;
- Kozera, Lukasz;
- Bréchot, Christian;
- Hofman, Paul;
- Dagher, Georges
Publication type:
Article
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates.
Published in:
Science Translational Medicine, 2014, v. 6, n. 261, p. 1, doi. 10.1126/scitranslmed.3009835
By:
- Yu, Y. Joy;
- Atwal, Jasvinder K.;
- Yin Zhang;
- Tong, Raymond K.;
- Wildsmith, Kristin R.;
- Tan, Christine;
- Bien-Ly, Nga;
- Hersom, Maria;
- Maloney, Janice A.;
- Meilandt, William J.;
- Bumbaca, Daniela;
- Gadkar, Kapil;
- Hoyte, Kwame;
- Luk, Wilman;
- Yanmei Lu;
- Ernst, James A.;
- Scearce-Levie, Kimberly;
- Couch, Jessica A.;
- Dennis, Mark S.;
- Watts, Ryan J.
Publication type:
Article
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.
Published in:
Science Translational Medicine, 2014, v. 6, n. 261, p. 1, doi. 10.1126/scitranslmed.3009185
By:
- Swadling, Leo;
- Capone, Stefania;
- Antrobus, Richard D.;
- Brown, Anthony;
- Richardson, Rachel;
- Newell, Evan W.;
- Halliday, John;
- Kelly, Christabel;
- Bowen, Dan;
- Fergusson, Joannah;
- Kurioka, Ayako;
- Ammendola, Virginia;
- Del Sorbo, Mariarosaria;
- Grazioli, Fabiana;
- Esposito, Maria Luisa;
- Siani, Loredana;
- Traboni, Cinzia;
- Hill, Adrian;
- Colloca, Stefano;
- Davis, Mark
Publication type:
Article
Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.
Published in:
Science Translational Medicine, 2014, v. 6, n. 261, p. 1, doi. 10.1126/scitranslmed.3009318
By:
- Laughney, Ashley M.;
- Eunha Kim;
- Sprachman, Melissa M.;
- Miller, Miles A.;
- Kohler, Rainer H.;
- Yang, Katy S.;
- Orth, James D.;
- Mitchison, Timothy J.;
- Weissleder, Ralph
Publication type:
Article
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.
Published in:
Science Translational Medicine, 2014, v. 6, n. 261, p. 1, doi. 10.1126/scitranslmed.3010162
By:
- Adusumilli, Prasad S.;
- Cherkassky, Leonid;
- Villena-Vargas, Jonathan;
- Colovos, Christos;
- Servais, Elliot;
- Plotkin, Jason;
- Jones, David R.;
- Sadelain, Michel
Publication type:
Article

Works matching IS 19466234 AND DT 2014 AND VI 6 AND IP 261

Public Biobanks: Calculation and Recovery of Costs.

Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates.

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin.

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.